California Nanotechnologies (TSXV:CNO) EBIT per Share: C$-0.05 (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:CNO California Nanotechnologies Corp TSXV:CNO
41 GF Score
Price C$0.34
GF Value C$0.30
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is California Nanotechnologies EBIT per Share?

California Nanotechnologies TSXV:CNO -2.86% 41 EBIT per Share is C$-0.05 as of Feb. 2026. GuruFocus rates TSXV:CNO with a GF Score™ of 41/100 and a GF Value™ of C$0.30 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 1,338 Chemicals companies, California Nanotechnologies ranks worse than 74738.34% on this metric.

California Nanotechnologies's EBIT per Share for the three months ended in Feb. 2026 was C$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 was C$-0.05.

During the past 12 months, the average EBIT per Share Growth Rate of California Nanotechnologies was -229.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for California Nanotechnologies's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of California Nanotechnologies was 100.00% per year. The lowest was -79.70% per year. And the median was 14.10% per year.

TSXV:CNO's 3-Year EBIT Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: -1.15
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

California Nanotechnologies's EBIT for the three months ended in Feb. 2026 was C$0.02 Mil.


California Nanotechnologies  (TSXV:CNO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


California Nanotechnologies EBIT per Share Related Terms


California Nanotechnologies EBIT per Share Historical Data

* Premium members only.

The historical data trend for California Nanotechnologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

California Nanotechnologies EBIT per Share Chart

California Nanotechnologies Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.01 -0.05

California Nanotechnologies Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.01 -0.01 -0.03 0.00
TSXV:CNO
41GF Score
California Nanotechnologies Corp TSXV:CNO
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

California Nanotechnologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

California Nanotechnologies's EBIT per Share for the fiscal year that ended in Feb. 2026 is calculated as

EBIT per Share(A: Feb. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.358/45.534
=-0.05

California Nanotechnologies's EBIT per Share for the quarter that ended in Feb. 2026 is calculated as

EBIT per Share(Q: Feb. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=0.015/39.557
=0.00

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of C$-0.05 mean?
California Nanotechnologies (TSXV:CNO) has a EBIT per Share of C$-0.05 as of Feb. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on California Nanotechnologies and its competitors. According to the industry distribution chart, California Nanotechnologies ranks #999999 out of 1338 companies in the Chemicals industry.
Is California Nanotechnologies' EBIT per Share too high?
California Nanotechnologies' current EBIT per Share is C$-0.05. Based on the distribution chart, California Nanotechnologies ranks #999999 out of 1338 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, California Nanotechnologies has a GF Score™ of 41/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, California Nanotechnologies ranks #999999 out of 1338 companies for EBIT per Share. This places California Nanotechnologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on California Nanotechnologies and its competitors. California Nanotechnologies's current EBIT per Share is C$-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (TSXV:CNO) is currently considered Modestly Overvalued. The stock's GF Value™ is C$0.30, compared to a current price of C$0.34 — trading 13.3% above its estimated fair value. The current EBIT per Share is C$-0.05. California Nanotechnologies' overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For California Nanotechnologies (TSXV:CNO), the current EBIT per Share is C$-0.05 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is California Nanotechnologies (TSXV:CNO) Overvalued in 2026?

Based on GuruFocus' analysis, California Nanotechnologies stock appears to be overvalued. The current stock price of C$0.34 is trading 13.3% above its estimated GF Value™ of C$0.30. GuruFocus considers California Nanotechnologies to be Modestly Overvalued.

Key valuation signals for TSXV:CNO:

  • EBIT per Share: C$-0.05
  • GF Value™: C$0.30 vs. price of C$0.34 (13.3% above fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the TSXV:CNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


California Nanotechnologies Business Description

Other Exchanges CANOF:USAR14:Germany
Address 110 Yonge Street, Suite 1601, Toronto, ON, CAN, M5C 1T4
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
41GF Score

Get the complete analysis for TSXV:CNO

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.34
Price
C$0.30
GF Value